Association between transforming growth factor 1 polymorphisms and atrial fibrillation in essential hypertensive subjects

Journal of Biomedical Science

Volumn 17, Issue 1, 2010, Pages

  Wang, Yongzheng ^a   Hou, Xuwei ^b   Li, Yuliang ^a  

^a SHANDONG UNIVERSITY   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CODON; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GENE FREQUENCY; GENOTYPE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK FACTOR; SINUS RHYTHM; BLOOD; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HYPERTENSION; MIDDLE AGED;

ATRIAL FIBRILLATION; CODON; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MIDDLE AGED; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77950449013     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-23     Document Type: Article

References (33)

1. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. Z Zhou D Hu, J Epidemiol 2008 18 209 216 10.2188/jea.JE2008021 18776706
2. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. S Stewart NF Murphy A Walker A McGuire JJ McMurray, Heart 2004 90 286 292 10.1136/hrt.2002.008748 14966048 (Pubitemid 38250721)
3. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. DM Lloyd-Jones TJ Wang EP Leip MG Larson D Levy RS Vasan RB D'Agostino JM Massaro A Beiser PA Wolf EJ Benjamin, Circulation 2004 110 1042 1046 10.1161/01.CIR.0000140263.20897.42 15313941 (Pubitemid 39319000)
4. Risk factors for new-onset atrial fibrillation during routine medical checkups of Japanese male workers. M Minami Y Kobayashi S Toyokawa K Inoue Y Takeshita, Int Heart J 2009 50 457 464 10.1536/ihj.50.457 19609050
5. [Arterial hypertension and cardiac arrhythmias]. EG Vester, Dtsch Med Wochenschr 2008 133 Suppl 8 261 265 10.1055/s-0028-1100958 19085803
6. Hypertension and atrial fibrillation. O Go C Rosendorff, Curr Cardiol Rep 2009 11 430 435 10.1007/s11886-009-0062-4 19863867
7. Atrial fibrosis in heart surgery patients Decreased collagen III/I ratio in postoperative atrial fibrillation. JB Grammer J Bohm A Dufour M Benz R Lange R Bauernschmitt, Basic Res Cardiol 2005 100 288 294 10.1007/s00395-005-0515-x 15690103 (Pubitemid 41348820)
8. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. A Boldt U Wetzel J Lauschke J Weigl J Gummert G Hindricks H Kottkamp S Dhein, Heart 2004 90 400 405 10.1136/hrt.2003.015347 15020515 (Pubitemid 38406914)
9. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. B Burstein S Nattel, J Am Coll Cardiol 2008 51 802 809 10.1016/j.jacc.2007.09.064 18294563 (Pubitemid 351260071)
10. Atrial fibrosis and the mechanisms of atrial fibrillation. THt Everett JE Olgin, Heart Rhythm 2007 4 24 27 10.1016/j.hrthm.2006.12.040 17336879
11. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. A Frustaci C Chimenti F Bellocci E Morgante MA Russo A Maseri, Circulation 1997 96 1180 1184 9286947 (Pubitemid 27344221)
12. Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke? A Goette, Cardiovasc Res 2009 83 421 422 10.1093/cvr/cvp188 19502283
13. Fibrosis of collagen I and remodeling of connexin 43 in atrial myocardium of patients with atrial fibrillation. MH Luo YS Li KP Yang, Cardiology 2007 107 248 253 10.1159/000095501 16953110 (Pubitemid 46788240)
14. Extracellular matrix remodeling in atrial fibrosis: Mechanisms and implications in atrial fibrillation. J Pellman RC Lyon F Sheikh, J Mol Cell Cardiol 2009 19751740
15. Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation. MS Spach, Circ Res 2007 101 743 745 10.1161/CIRCRESAHA.107.163956 17932329
16. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. S Verheule T Sato T Everett SK Engle D Otten M Rubart-von der Lohe HO Nakajima H Nakajima LJ Field JE Olgin, Circ Res 2004 94 1458 1465 10.1161/01.RES.0000129579.59664.9d 15117823 (Pubitemid 38780318)
17. Atrial fibrosis and atrial fibrillation: The role of the TGF-beta(1) signaling pathway. F Gramley J Lorenzen E Koellensperger K Kettering C Weiss T Munzel, Int J Cardiol 2009 19394095
18. Impact of transforming growth factor-beta1 on atrioventricular node conduction modification by injected autologous fibroblasts in the canine heart. TJ Bunch S Mahapatra GK Bruce SB Johnson DV Miller BD Horne XL Wang HC Lee NM Caplice DL Packer, Circulation 2006 113 2485 2494 10.1161/CIRCULATIONAHA.105. 570796 16717152 (Pubitemid 43948026)
19. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. F Cambien S Ricard A Troesch C Mallet L Générénaz A Evans D Arveiler G Luc JB Ruidavets O Poirier, Hypertension 1996 28 881 887 8901839 (Pubitemid 26365534)
20. Role of TGF-beta1 haplotypes in the occurrence of myocardial infarction in young Italian patients. F Crobu L Palumbo E Franco S Bergerone S Carturan S Guarrera S Frea G Trevi A Piazza G Matullo, BMC medical genetics 2008 9 13 10.1186/1471-2350-9-13 18312614 (Pubitemid 351454854)
21. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease. W Koch P Hoppmann JC Mueller A Schomig A Kastrati, Arteriosclerosis, thrombosis, and vascular biology 2006 26 1114 1119 10.1161/01.ATV.0000217747. 66517.11 16543493 (Pubitemid 43732120)
22. Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients. M Rao D Guo BL Jaber H Tighiouart BJ Pereira VS Balakrishnan, Kidney international 2004 66 419 427 10.1111/j.1523-1755.2004. 00748.x 15200451 (Pubitemid 38870120)
23. TGF-beta1 polymorphisms and arterial stiffness; the Rotterdam Study. MP Sie FU Mattace-Raso AG Uitterlinden PP Arp A Hofman AP Hoeks RS Reneman R Asmar CM van Duijn JC Witteman, Journal of human hypertension 2007 21 431 437 17361195 (Pubitemid 46813592)
24. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. P Syrris ND Carter JC Metcalfe PR Kemp DJ Grainger JC Kaski DC Crossman SE Francis J Gunn S Jeffery K Heathcote, Clin Sci (Lond) 1998 95 659 667 10.1042/CS19980154 9831690 (Pubitemid 29034430)
25. Association between transforming growth factor beta1 polymorphisms and left ventricle hypertrophy in essential hypertensive subjects. HY Xu XW Hou LF Wang NF Wang J Xu, Molecular and cellular biochemistry 2009 335 13 17 10.1007/s11010-009-0235-x 19728040
26. Genetic control of the circulating concentration of transforming growth factor type beta1. DJ Grainger K Heathcote M Chiano H Snieder PR Kemp JC Metcalfe ND Carter TD Spector, Human molecular genetics 1999 8 93 97 10.1093/hmg/8.1.93 9887336 (Pubitemid 29039053)
27. Circulating transforming growth factor beta-1: a partial molecular explanation for associations between hypertension, diabetes, obesity, smoking and human disease involving fibrosis. MC Peterson, Med Sci Monit 2005 11 A229 232 15990699
28. Transforming growth factor beta in hypertensives with cardiorenal damage. C Laviades N Varo J Diez, Hypertension 2000 36 517 522 11040229
29. Transforming growth factor-beta(1) expression in dilated cardiomyopathy. JE Sanderson KB Lai IO Shum S Wei LT Chow, Heart (British Cardiac Society) 2001 86 701 708 11711472
30. ctivin-A, transforming growth factor-beta, and myostatin signaling pathway in experimental dilated cardiomyopathy. M Mahmoudabady M Mathieu L Dewachter I Hadad L Ray P Jespers S Brimioulle R Naeije K McEntee, Journal of cardiac failure 2008 14 703 709 10.1016/j.cardfail.2008.05.003 18926443
31. Increased levels of transforming growth factor-beta1 in essential hypertension. U Derhaschnig M Shehata H Herkner A Bur C Woisetschläger AN Laggner MM Hirschl, American journal of hypertension 2002 15 207 211 10.1016/S0895-7061(01)02327-5 11939608 (Pubitemid 34226183)
32. Transforming growth factor-beta: association with arteriosclerosis and left ventricular dysfunction after heart transplantation. TM Aziz M Burgess PS Hasleton N Yonan AK Deiraniya IV Hutchinson, Transplantation proceedings 2001 33 2334 2336 10.1016/S0041-1345(01)02013-9 11377551 (Pubitemid 33762733)
33. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. MR Awad A El-Gamel P Hasleton DM Turner PJ Sinnott IV Hutchinson, Transplantation 1998 66 1014 1020 10.1097/00007890-199810270-00009 9808485 (Pubitemid 28513380)